AI Business · · 5 min read
How Do Health Systems Vet AI Amidst a Proliferation of Vendors?
We explain why TestDynamics' $9 million funding highlights the urgent need for robust AI evaluation in healthcare and what it means for business leaders.

On November 16, 2026, Axios exclusively reported a significant development in the healthcare AI landscape: TestDynamics, a New York City-based company founded in 2020, secured a robust $9 million in Series A funding.
This capital injection, according to Axios, is earmarked for one crucial purpose: expanding its platform for evaluating medical imaging algorithms.
Led by CEO Lior Eshel, the company, with its compact team of 13 employees as of September 30, 2026, is tackling a challenge that's quietly growing into a major headache for health systems globally.
But that's not the interesting part. The real story isn't just about a startup raising money; it's about the underlying problem TestDynamics aims to solve.
Axios noted that as AI vendors flood the market, health systems are increasingly seeking tools to vet them. This highlights a critical need, not just in the US, but globally.
That raises three questions.
Question 1
What is TestDynamics and Why Did It Secure $9 Million?
TestDynamics is an AI-based medical imaging tool designed for healthcare professionals. Its core mission, as described by Axios, is to make AI more accessible to physicians, hospitals, and patients by ensuring the reliability of these advanced tools.
For context, medical imaging AI algorithms are sophisticated software programs that can analyse X-rays, MRIs, and CT scans to help detect diseases, highlight anomalies, or even predict patient outcomes. They are becoming increasingly common in clinical practice, promising faster diagnoses and improved accuracy.
The $9 million Series A funding, backed by institutional investors like Silvertech Ventures and Two World Ventures, directly addresses a burgeoning market need. Axios reported that 'As AI vendors proliferate, health systems are increasingly turning to tools to vet them.' This is the crux of the problem: as more and more companies develop AI solutions for diagnostics, hospitals face a dilemma.
How do they know which ones actually work as promised, and which are just marketing hype? TestDynamics aims to be the independent arbiter, providing a crucial layer of verification.
Consider the sheer volume: TestDynamics operates in a market with 142 active competitors, and 27 of those are already funded, according to research notes from Google Search. This isn't just a niche; it's a crowded space where every vendor claims superiority. Without a reliable way to compare and validate, how can a hospital make an informed, patient-centric decision? This funding signals investor confidence in TestDynamics' ability to fill that critical gap.
Question 2
How Do Platforms Like TestDynamics Evaluate Medical Imaging AI?
TestDynamics' platform integrates a wide range of AI algorithms and streamlines automated workflows. Its goal is to support clinical decision-making by giving healthcare providers confidence in the AI tools they use. But how does it actually do this? What exactly does 'evaluating' AI entail?
Think of it like a meticulous kirana store owner sourcing rice for their customers. The owner doesn't just buy any bag of rice; they test samples, check the quality, ensure it meets standards, and verify the supplier's claims before stocking it. They might cook a small batch, check for broken grains, or even ask trusted customers for feedback. This ensures customers get good, reliable rice, bag after bag.
Similarly, TestDynamics acts as that quality control for AI algorithms. It tests these complex programs against real-world, diverse datasets (not just the perfect data the vendor might provide). This involves running algorithms through various scenarios, checking their accuracy in identifying specific conditions, evaluating their consistency across different patient demographics, and assessing their performance under varying imaging conditions.
The platform automates these rigorous tests, generating objective reports that health systems can use. This independent evaluation helps hospitals choose AI tools that are truly effective, safe, and unbiased for patient care, rather than relying solely on a vendor's potentially biased claims. It's about moving from 'trust me' to 'show me the data.' And that brings us to the third question.
Question 3
What Does the Rise of AI Vetting Platforms Mean for Health Systems in India?
The market for medical imaging AI is undeniably crowded. As we noted, TestDynamics faces 142 active competitors, with 27 of them already funded. This intense competition underscores the rapid proliferation of AI solutions and, consequently, the urgent need for robust, independent evaluation. What does this mean for health systems here in India?
For health systems in India, this trend is particularly relevant. As AI adoption accelerates in sectors like healthcare, ensuring the efficacy and safety of these tools becomes paramount. Indian hospitals, much like their global counterparts, need to be able to distinguish between truly beneficial AI and solutions that might be untested, unreliable, or even misleading.
Imagine a diagnostic AI that performs brilliantly on Western datasets but struggles with the nuances of Indian patient demographics or imaging protocols. How would a hospital know without independent vetting? The costs of deploying an ineffective or biased AI, both in terms of patient outcomes and financial resources, can be substantial.
Platforms like TestDynamics offer a crucial layer of trust and accountability. By providing objective evaluations, they empower healthcare leaders to make informed decisions about AI investments, ultimately safeguarding patient outcomes and optimising operational efficiency. It means a future where AI in healthcare is not just innovative, but also reliably integrated into patient care pathways. Are Indian hospitals ready to implement such rigorous vetting processes, or will they lag behind?
The Bigger Picture
The story of TestDynamics' funding isn't just about a company growing; it's a clear signal of a maturing AI market in healthcare. It reflects a broader shift across all sectors where AI is being deployed.
As AI moves from an experimental novelty to a mainstream clinical tool, or indeed, a core business function, the focus shifts dramatically. It's no longer just about building AI; it's about building the infrastructure of trust around it.
For business leaders across manufacturing, retail, logistics, or services, this trend highlights a universal truth: any AI solution, no matter how clever, is only as valuable as its proven reliability and trustworthiness.
Can your business afford to deploy AI without understanding how it truly performs in your specific context? The answer, increasingly, is no. Reliability is the new frontier for AI adoption, and companies that enable that trust will thrive.
The future of AI isn't just about intelligence; it's about verifiable integrity.
Quick Answers
What is TestDynamics?
TestDynamics is a New York City-based company founded in 2020 that provides an AI-based platform for evaluating medical imaging algorithms, helping healthcare professionals ensure the reliability of AI tools.
Why did TestDynamics raise $9 million?
TestDynamics secured $9 million in Series A funding to expand its platform for evaluating medical imaging algorithms, addressing the growing need for health systems to vet the increasing number of AI vendors.
How do AI vetting platforms benefit health systems?
AI vetting platforms like TestDynamics integrate and test various AI algorithms, providing objective evaluations that help health systems make informed decisions, ensure patient safety, and optimise the use of AI in diagnostics.
Sources
- Axios16 Nov · 18:04 IST
- www.tokenpost.com16 Nov · 18:01 IST
Facts are credited to the outlets above. The analysis, calculations and Signal Check are by the Finnect AI Insights desk.